Pain Therapeutics Market

Pain Therapeutics Market Highlights

The global pain therapeutics market is expected to cross a value of USD 106.7 billion by the end of 2032. The market was valued at USD 79.2 billion in 2023 and is expected to expand at a CAGR of 4.1% between 2024-2032.

• Over the mid-term, the rise in prevalence of chronic pain is the primary factor anticipated to drive the global pain therapeutics market.
• The growing concern for regulatory challenges and compliance is a major factor to challenge the market growth.
• The North America pain therapeutics market is projected to dominate the global market.

Pain Therapeutics Market Outlook

Pain therapeutics are a broad range of medical treatments, medications, and interventions designed to alleviate or manage pain. Also known as pain management or analgesics, these encompasses pharmaceutical drugs, such as nonsteroidal anti-inflammatory drugs (NSAIDs), opioids, anticonvulsants, antidepressants, and topical agents, which target different mechanisms involved in pain sensation and transmission.

According to our experts at KD Market Insights, the rise in prevalence of chronic pain is one of the primary factors associated with the growth of the global pain therapeutics market. Chronic pain conditions such as arthritis, lower back pain, neuropathic pain, and cancer-related pain are becoming more prevalent globally due to factors such as aging populations, sedentary lifestyles, and rising incidences of chronic diseases. This growing prevalence drives the demand for effective pain therapeutics. Pfizer Inc., Johnson & Johnson, Eli Lilly and Company are some of the significant parties in the global market for pain therapeutics.

                                   Get More Insights on This Report - Request Free Sample PDF

Pain Therapeutics Market Drivers – Analyst’s Observation

According to the analysts at KD Market Insights, some key growth drivers for the global pain therapeutics market are:

• Expanding Geriatric Population Globally: The aging population worldwide, which according to the World Health Organization (WHO), is expected to double to 2.1 billion by 2050, is a significant contributor to the growth of the pain therapeutics market. Elderly individuals are more prone to chronic pain conditions due to age-related degenerative changes. This, as a result, is leading to a higher demand for pain management medications and treatments tailored to their specific needs, which is expected to drive the demand for pain therapeutics.
• Growing Awareness Among Healthcare Professionals for Adequate Pain Management: The rise in awareness among healthcare professionals and patients regarding the importance of adequate pain management is expected to drive the demand for pain therapeutics. Rapid educational campaigns, advocacy efforts, and improved pain assessment tools contribute to a greater recognition of the need for effective pain relief, which is expected to drive the market growth.

Which Probable Factors Could Hamper the Growing Pain Therapeutics Market Trend?

As per our KD Market Insights analysis, some of the challenges expected to limit the global market growth of pain therapeutics are:

• Concern for Regulatory Challenges and Compliance: Stringent regulatory requirements for the approval, manufacturing, and marketing of pain therapeutics is one of the major factors expected to limit the market growth.
• Growing Opioid Epidemic and Regulatory Scrutiny: The opioid epidemic has led to heightened regulatory scrutiny and restrictions on opioid prescribing and distribution. Measures aimed at combating opioid misuse and abuse, such as prescription monitoring programs and opioid prescribing guidelines, have resulted in decreased opioid prescriptions and increased caution among healthcare providers, potentially limiting the market growth of opioid-based pain therapeutics.

How is the Global Pain Therapeutics Market Segmented?

Our experts at KD Market Insights have segmented the global pain therapeutics market as:

What are the Probable Factors Influencing the North America Pain Therapeutics Market Forecast?

The North America pain therapeutics market is majorly driven by the growing technological advancements in pain management technologies, growing ageing population, and the surge in prevalence of chronic diseases in the region. North America has a rapidly aging population, with a significant proportion of individuals experiencing age-related chronic pain conditions such as osteoarthritis, neuropathy, and back pain. On the other hand, chronic diseases such as diabetes, cancer, and cardiovascular conditions are on the rise in the region, which is also expected to raise the demand for pain therapeutics.

As per our analysts at KD Market Insights, the following five players lead the North America pain therapeutics market growth:

• Pfizer Inc.
• Johnson & Johnson
• Purdue Pharma L.P.
• Mallinckrodt Pharmaceuticals
• Endo International plc

Which Key Players Top the Global Pain Therapeutics Market Share?

As per our analysts at KD Market Insights, the competitive landscape of global pain therapeutics market facilitates our readers in identifying their closest competitors. The manufacturers who are associated with pain therapeutics market are raising their focus on expanding their presence, as well as their market share. The market has also been witnessing an upward movement in the number of collaborations between research institutions and key players, aimed at introducing advanced technologies and innovation of new products. Here is a list of the key players who top the global pain therapeutics market share:

• Pfizer Inc.
• Johnson & Johnson
• Eli Lilly and Company
• Novartis AG
• Teva Pharmaceutical Industries Ltd.
• AbbVie Inc.
• GlaxoSmithKline plc
• AstraZeneca plc
• Purdue Pharma L.P.
• Mallinckrodt Pharmaceuticals
• Endo International plc
• Allergan plc

What are the Recent Developments Observed in the Pain Therapeutics Market?

Over the years, the experts at KD Market Insights have been observing the recent developments associated with global pain therapeutics market trends. Our expert’s market forecast analysis has recorded the market players adopting plentiful of key strategies including new product launches, mergers & acquisitions, and collaborations.

For instance, Abeona Therapeutics stated that it has received positive results for its VIITALTM study of EB-101, which is at its pivotal Phase 3, with both co-primary endpoints.

Further, Venus Remedies Limited shared that it has established a separate consumer healthcare subsidiary. This new subsidiary would provide advanced pain diagnostics and solutions.

1. Preface
 1.1. Research Methodology
 1.2. Geographic Scope
 1.3. Years Considered

2. Executive Summary

3. Market Overview
 3.1. Pain Therapeutics Overview
 3.2. Market Definition & Key Market Segments
 3.3. Industry Development
 3.4. Global Market Maturity
 3.4.1. North America
 3.4.2. Europe
 3.4.3. Asia Pacific
 3.4.4. Latin America
 3.4.5. Middle East & Africa
 3.5. Porter’s Five Force Analysis
 3.6. Industry Value Chain Analysis
 3.7. Macro-Economic Trends

4. Competitive Landscape
 4.1. Global Pain Therapeutics Market 2021
 4.2. Global Pain Therapeutics Market Value Share, By Company 2021
 4.3. Global Pain Therapeutics Market Volume Share, By Company 2021

5. Growth Drivers & Barriers in Global Pain Therapeutics Market
 5.1. North America
 5.2. Europe
 5.3. Asia Pacific
 5.4. Rest of World

6. Trends in Global Pain Therapeutics Market
 6.1. North America
 6.2. Europe
 6.3. Asia Pacific
 6.4. Rest of World

7. Global Pain Therapeutics Market
 7.1. Introduction
 7.2. Historical Market Value2016-2021 Market Value Forecast & Y-o-Y Growth Analysis, 2021-2027

8. Global Pain Therapeutics Market Segmentation Analysis, By Drug Class
 8.1. Introduction
 8.2. Strategic Insights
 8.2.1. BPS Analysis, By Drug Class
 8.2.2. Market Attractiveness, By Drug Class
 8.3. NSAIDs
 8.3.1. Historical Market Value2016-2021 Market Value Forecast & Y-o-Y Growth Analysis, 2021-2027
 8.4. Anesthetics
 8.4.1. Historical Market Value2016-2021 Market Value Forecast & Y-o-Y Growth Analysis, 2021-2027
 8.5. Anticonvulsants
 8.5.1. Historical Market Value2016-2021 Market Value Forecast & Y-o-Y Growth Analysis, 2021-2027
 8.6. Antimigraine Agents
 8.6.1. Historical Market Value2016-2021 Market Value Forecast & Y-o-Y Growth Analysis, 2021-2027
 8.7. Antidepressants
 8.7.1. Historical Market Value2016-2021 Market Value Forecast & Y-o-Y Growth Analysis, 2021-2027
 8.8. Opioids
 8.8.1. Historical Market Value2016-2021 Market Value Forecast & Y-o-Y Growth Analysis, 2021-2027
 8.8.2. Tramadol
 8.8.2.1. Historical Market Value2016-2021 Market Value Forecast & Y-o-Y Growth Analysis, 2021-2027
 8.8.3. Hydrocodone
 8.8.3.1. Historical Market Value2016-2021 Market Value Forecast & Y-o-Y Growth Analysis, 2021-2027
 8.8.4. Oxycodone
 8.8.4.1. Historical Market Value2016-2021 Market Value Forecast & Y-o-Y Growth Analysis, 2021-2027
 8.8.5. Others
 8.8.5.1. Historical Market Value2016-2021 Market Value Forecast & Y-o-Y Growth Analysis, 2021-2027
 8.9. Nonnarcotic Analgesics
 8.9.1.1. Historical Market Value2016-2021 Market Value Forecast & Y-o-Y Growth Analysis, 2021-2027

9. Global Pain Therapeutics Market Segmentation Analysis, By Indication
 9.1. Introduction
 9.2. Strategic Insights
 9.2.1. BPS Analysis, By Indication
 9.2.2. Market Attractiveness, By Indication
 9.3. Arthritic Pain
 9.3.1. Historical Market Value2016-2021 Market Value Forecast & Y-o-Y Growth Analysis, 2021-2027
 9.4. Neuropathic Pain
 9.4.1. Historical Market Value2016-2021 Market Value Forecast & Y-o-Y Growth Analysis, 2021-2027
 9.5. Cancer Pain
 9.5.1. Historical Market Value2016-2021 Market Value Forecast & Y-o-Y Growth Analysis, 2021-2027
 9.6. Chronic Back Pain
 9.6.1. Historical Market Value2016-2021 Market Value Forecast & Y-o-Y Growth Analysis, 2021-2027
 9.7. Postoperative Pain
 9.7.1. Historical Market Value2016-2021 Market Value Forecast & Y-o-Y Growth Analysis, 2021-2027
 9.8. Migraine
 9.8.1. Historical Market Value2016-2021 Market Value Forecast & Y-o-Y Growth Analysis, 2021-2027
 9.9. Fibromyalgia
 9.9.1. Historical Market Value2016-2021 Market Value Forecast & Y-o-Y Growth Analysis, 2021-2027

10. Global Pain Therapeutics Market Segmentation Analysis, By Distribution Channel
 10.1. Introduction
 10.2. Strategic Insights
 10.2.1. BPS Analysis, By Distribution Channel
 10.2.2. Market Attractiveness, By Distribution Channel
 10.3. Hospitals Pharmacy
 10.3.1. Historical Market Value2016-2021 Market Value Forecast & Y-o-Y Growth Analysis, 2021-2027
 10.4. Retail Pharmacy
 10.4.1. Historical Market Value2016-2021 Market Value Forecast & Y-o-Y Growth Analysis, 2021-2027
 10.5. Online Pharmacy
 10.5.1. Historical Market Value2016-2021 Market Value Forecast & Y-o-Y Growth Analysis, 2021-2027

11. Geographical Analysis
 11.1. Introduction
 11.2. North America Pain Therapeutics Market
 11.2.1. Historical Market Value2016-2021 Market Value Forecast & Y-o-Y Growth Analysis, 2021-2027
 11.2.2. By Drug Class
 11.2.2.1. Introduction
 11.2.2.2. Strategic Insights
 11.2.2.2.1. BPS Analysis, By Drug Class
 11.2.2.2.2. Market Attractiveness, By Drug Class
 11.2.2.3. NSAIDs
 11.2.2.3.1. Historical Market Value2016-2021 Market Value Forecast & Y-o-Y Growth Analysis, 2021-2027
 11.2.2.4. Anesthetics
 11.2.2.4.1. Historical Market Value2016-2021 Market Value Forecast & Y-o-Y Growth Analysis, 2021-2027
 11.2.2.5. Anticonvulsants
 11.2.2.5.1. Historical Market Value2016-2021 Market Value Forecast & Y-o-Y Growth Analysis, 2021-2027
 11.2.2.6. Antimigraine Agents
 11.2.2.6.1. Historical Market Value2016-2021 Market Value Forecast & Y-o-Y Growth Analysis, 2021-2027
 11.2.2.7. Antidepressants
 11.2.2.7.1. Historical Market Value2016-2021 Market Value Forecast & Y-o-Y Growth Analysis, 2021-2027
 11.2.2.8. Opioids
 11.2.2.8.1. Historical Market Value2016-2021 Market Value Forecast & Y-o-Y Growth Analysis, 2021-2027
 11.2.2.8.2. Tramadol
 11.2.2.8.2.1. Historical Market Value2016-2021 Market Value Forecast & Y-o-Y Growth Analysis, 2021-2027
 11.2.2.8.3. Hydrocodone
 11.2.2.8.3.1. Historical Market Value2016-2021 Market Value Forecast & Y-o-Y Growth Analysis, 2021-2027
 11.2.2.8.4. Oxycodone
 11.2.2.8.4.1. Historical Market Value2016-2021 Market Value Forecast & Y-o-Y Growth Analysis, 2021-2027
 11.2.2.8.5. Others
 11.2.2.8.5.1. Historical Market Value2016-2021 Market Value Forecast & Y-o-Y Growth Analysis, 2021-2027
 11.2.2.9. Nonnarcotic Analgesics
 11.2.2.9.1.1. Historical Market Value2016-2021 Market Value Forecast & Y-o-Y Growth Analysis, 2021-2027
 11.2.3. By Indication
 11.2.3.1. Introduction
 11.2.3.2. Strategic Insights
 11.2.3.2.1. BPS Analysis, By Indication
 11.2.3.2.2. Market Attractiveness, By Indication
 11.2.3.3. Arthritic Pain
 11.2.3.3.1. Historical Market Value2016-2021 Market Value Forecast & Y-o-Y Growth Analysis, 2021-2027
 11.2.3.4. Neuropathic Pain
 11.2.3.4.1. Historical Market Value2016-2021 Market Value Forecast & Y-o-Y Growth Analysis, 2021-2027
 11.2.3.5. Cancer Pain
 11.2.3.5.1. Historical Market Value2016-2021 Market Value Forecast & Y-o-Y Growth Analysis, 2021-2027
 11.2.3.6. Chronic Back Pain
 11.2.3.6.1. Historical Market Value2016-2021 Market Value Forecast & Y-o-Y Growth Analysis, 2021-2027
 11.2.3.7. Postoperative Pain
 11.2.3.7.1. Historical Market Value2016-2021 Market Value Forecast & Y-o-Y Growth Analysis, 2021-2027
 11.2.3.8. Migraine
 11.2.3.8.1. Historical Market Value2016-2021 Market Value Forecast & Y-o-Y Growth Analysis, 2021-2027
 11.2.3.9. Fibromyalgia
 11.2.3.9.1. Historical Market Value2016-2021 Market Value Forecast & Y-o-Y Growth Analysis, 2021-2027
 11.2.4. By Distribution Channel
 11.2.4.1. Introduction
 11.2.4.2. Strategic Insights
 11.2.4.2.1. BPS Analysis, By Distribution Channel
 11.2.4.2.2. Market Attractiveness, By Distribution Channel
 11.2.4.3. Hospitals Pharmacy
 11.2.4.3.1. Historical Market Value2016-2021 Market Value Forecast & Y-o-Y Growth Analysis, 2021-2027
 11.2.4.4. Retail Pharmacy
 11.2.4.4.1. Historical Market Value2016-2021 Market Value Forecast & Y-o-Y Growth Analysis, 2021-2027
 11.2.4.5. Online Pharmacy
 11.2.4.5.1. Historical Market Value2016-2021 Market Value Forecast & Y-o-Y Growth Analysis, 2021-2027
 11.2.5. By Country
 11.2.5.1. Introduction
 11.2.5.2. Strategic Insights
 11.2.5.2.1. BPS Analysis, By Country
 11.2.5.2.2. Market Attractiveness, By Country
 11.2.5.3. U.S. Pain Therapeutics Market
 11.2.5.3.1. Historical Market Value2016-2021 Market Value Forecast & Y-o-Y Growth Analysis, 2021-2027
 11.2.5.4. Canada Pain Therapeutics Market
 11.2.5.4.1. Historical Market Value2016-2021 Market Value Forecast & Y-o-Y Growth Analysis, 2021-2027

11.3. Europe Pain Therapeutics Market
 11.3.1. Historical Market Value2016-2021 Market Value Forecast & Y-o-Y Growth Analysis, 2021-2027
 11.3.2. By Drug Class
 11.3.2.1. Introduction
 11.3.2.2. Strategic Insights
 11.3.2.2.1. BPS Analysis, By Drug Class
 11.3.2.2.2. Market Attractiveness, By Drug Class
 11.3.2.3. NSAIDs
 11.3.2.3.1. Historical Market Value2016-2021 Market Value Forecast & Y-o-Y Growth Analysis, 2021-2027
 11.3.2.4. Anesthetics
 11.3.2.4.1. Historical Market Value2016-2021 Market Value Forecast & Y-o-Y Growth Analysis, 2021-2027
 11.3.2.5. Anticonvulsants
 11.3.2.5.1. Historical Market Value2016-2021 Market Value Forecast & Y-o-Y Growth Analysis, 2021-2027
 11.3.2.6. Antimigraine Agents
 11.3.2.6.1. Historical Market Value2016-2021 Market Value Forecast & Y-o-Y Growth Analysis, 2021-2027
 11.3.2.7. Antidepressants
 11.3.2.7.1. Historical Market Value2016-2021 Market Value Forecast & Y-o-Y Growth Analysis, 2021-2027
 11.3.2.8. Opioids
 11.3.2.8.1. Historical Market Value2016-2021 Market Value Forecast & Y-o-Y Growth Analysis, 2021-2027
 11.3.2.8.2. Tramadol
 11.3.2.8.2.1. Historical Market Value2016-2021 Market Value Forecast & Y-o-Y Growth Analysis, 2021-2027
 11.3.2.8.3. Hydrocodone
 11.3.2.8.3.1. Historical Market Value2016-2021 Market Value Forecast & Y-o-Y Growth Analysis, 2021-2027
 11.3.2.8.4. Oxycodone
 11.3.2.8.4.1. Historical Market Value2016-2021 Market Value Forecast & Y-o-Y Growth Analysis, 2021-2027
 11.3.2.8.5. Others
 11.3.2.8.5.1. Historical Market Value2016-2021 Market Value Forecast & Y-o-Y Growth Analysis, 2021-2027
 11.3.2.9. Nonnarcotic Analgesics
 11.3.2.9.1.1. Historical Market Value2016-2021 Market Value Forecast & Y-o-Y Growth Analysis, 2021-2027
 11.3.3. By Indication
 11.3.3.1. Introduction
 11.3.3.2. Strategic Insights
 11.3.3.2.1. BPS Analysis, By Indication
 11.3.3.2.2. Market Attractiveness, By Indication
 11.3.3.3. Arthritic Pain
 11.3.3.3.1. Historical Market Value2016-2021 Market Value Forecast & Y-o-Y Growth Analysis, 2021-2027
 11.3.3.4. Neuropathic Pain
 11.3.3.4.1. Historical Market Value2016-2021 Market Value Forecast & Y-o-Y Growth Analysis, 2021-2027
 11.3.3.5. Cancer Pain
 11.3.3.5.1. Historical Market Value2016-2021 Market Value Forecast & Y-o-Y Growth Analysis, 2021-2027
 11.3.3.6. Chronic Back Pain
 11.3.3.6.1. Historical Market Value2016-2021 Market Value Forecast & Y-o-Y Growth Analysis, 2021-2027
 11.3.3.7. Postoperative Pain
 11.3.3.7.1. Historical Market Value2016-2021 Market Value Forecast & Y-o-Y Growth Analysis, 2021-2027
 11.3.3.8. Migraine
 11.3.3.8.1. Historical Market Value2016-2021 Market Value Forecast & Y-o-Y Growth Analysis, 2021-2027
 11.3.3.9. Fibromyalgia
 11.3.3.9.1. Historical Market Value2016-2021 Market Value Forecast & Y-o-Y Growth Analysis, 2021-2027
 11.3.4. By Distribution Channel
 11.3.4.1. Introduction
 11.3.4.2. Strategic Insights
 11.3.4.2.1. BPS Analysis, By Distribution Channel
 11.3.4.2.2. Market Attractiveness, By Distribution Channel
 11.3.4.3. Hospitals Pharmacy
 11.3.4.3.1. Historical Market Value2016-2021 Market Value Forecast & Y-o-Y Growth Analysis, 2021-2027
 11.3.4.4. Retail Pharmacy
 11.3.4.4.1. Historical Market Value2016-2021 Market Value Forecast & Y-o-Y Growth Analysis, 2021-2027
 11.3.4.5. Online Pharmacy
 11.3.4.5.1. Historical Market Value2016-2021 Market Value Forecast & Y-o-Y Growth Analysis, 2021-2027
 11.3.5. By Country
 11.3.5.1. Introduction
 11.3.5.2. Strategic Insights
 11.3.5.2.1. BPS Analysis, By Country
 11.3.5.2.2. Market Attractiveness, By Country
 11.3.5.3. Germany Pain Therapeutics Market
 11.3.5.3.1. Historical Market Value2016-2021 Market Value Forecast & Y-o-Y Growth Analysis, 2021-2027
 11.3.5.4. United Kingdom Pain Therapeutics Market
 11.3.5.4.1. Historical Market Value2016-2021 Market Value Forecast & Y-o-Y Growth Analysis, 2021-2027
 11.3.5.5. France Pain Therapeutics Market
 11.3.5.5.1. Historical Market Value2016-2021 Market Value Forecast & Y-o-Y Growth Analysis, 2021-2027
 11.3.5.6. Italy Pain Therapeutics Market
 11.3.5.6.1. Historical Market Value2016-2021 Market Value Forecast & Y-o-Y Growth Analysis, 2021-2027
 11.3.5.7. Spain Pain Therapeutics Market
 11.3.5.7.1. Historical Market Value2016-2021 Market Value Forecast & Y-o-Y Growth Analysis, 2021-2027
 11.3.5.8. Russia Pain Therapeutics Market
 11.3.5.8.1. Historical Market Value2016-2021 Market Value Forecast & Y-o-Y Growth Analysis, 2021-2027
 11.3.5.9. Rest of Europe Pain Therapeutics Market
 11.3.5.9.1. Historical Market Value2016-2021 Market Value Forecast & Y-o-Y Growth Analysis, 2021-2027

11.4. Asia Pacific Pain Therapeutics Market
 11.4.1. Historical Market Value2016-2021 Market Value Forecast & Y-o-Y Growth Analysis, 2021-2027
 11.4.2. By Drug Class
 11.4.2.1. Introduction
 11.4.2.2. Strategic Insights
 11.4.2.2.1. BPS Analysis, By Drug Class
 11.4.2.2.2. Market Attractiveness, By Drug Class
 11.4.2.3. NSAIDs
 11.4.2.3.1. Historical Market Value2016-2021 Market Value Forecast & Y-o-Y Growth Analysis, 2021-2027
 11.4.2.4. Anesthetics
 11.4.2.4.1. Historical Market Value2016-2021 Market Value Forecast & Y-o-Y Growth Analysis, 2021-2027
 11.4.2.5. Anticonvulsants
 11.4.2.5.1. Historical Market Value2016-2021 Market Value Forecast & Y-o-Y Growth Analysis, 2021-2027
 11.4.2.6. Antimigraine Agents
 11.4.2.6.1. Historical Market Value2016-2021 Market Value Forecast & Y-o-Y Growth Analysis, 2021-2027
 11.4.2.7. Antidepressants
 11.4.2.7.1. Historical Market Value2016-2021 Market Value Forecast & Y-o-Y Growth Analysis, 2021-2027
 11.4.2.8. Opioids
 11.4.2.8.1. Historical Market Value2016-2021 Market Value Forecast & Y-o-Y Growth Analysis, 2021-2027
 11.4.2.8.2. Tramadol
 11.4.2.8.2.1. Historical Market Value2016-2021 Market Value Forecast & Y-o-Y Growth Analysis, 2021-2027
 11.4.2.8.3. Hydrocodone
 11.4.2.8.3.1. Historical Market Value2016-2021 Market Value Forecast & Y-o-Y Growth Analysis, 2021-2027
 11.4.2.8.4. Oxycodone
 11.4.2.8.4.1. Historical Market Value2016-2021 Market Value Forecast & Y-o-Y Growth Analysis, 2021-2027
 11.4.2.8.5. Others
 11.4.2.8.5.1. Historical Market Value2016-2021 Market Value Forecast & Y-o-Y Growth Analysis, 2021-2027
 11.4.2.9. Nonnarcotic Analgesics
 11.4.2.9.1.1. Historical Market Value2016-2021 Market Value Forecast & Y-o-Y Growth Analysis, 2021-2027
 11.4.3. By Indication
 11.4.3.1. Introduction
 11.4.3.2. Strategic Insights
 11.4.3.2.1. BPS Analysis, By Indication
 11.4.3.2.2. Market Attractiveness, By Indication
 11.4.3.3. Arthritic Pain
 11.4.3.3.1. Historical Market Value2016-2021 Market Value Forecast & Y-o-Y Growth Analysis, 2021-2027
 11.4.3.4. Neuropathic Pain
 11.4.3.4.1. Historical Market Value2016-2021 Market Value Forecast & Y-o-Y Growth Analysis, 2021-2027
 11.4.3.5. Cancer Pain
 11.4.3.5.1. Historical Market Value2016-2021 Market Value Forecast & Y-o-Y Growth Analysis, 2021-2027
 11.4.3.6. Chronic Back Pain
 11.4.3.6.1. Historical Market Value2016-2021 Market Value Forecast & Y-o-Y Growth Analysis, 2021-2027
 11.4.3.7. Postoperative Pain
 11.4.3.7.1. Historical Market Value2016-2021 Market Value Forecast & Y-o-Y Growth Analysis, 2021-2027
 11.4.3.8. Migraine
 11.4.3.8.1. Historical Market Value2016-2021 Market Value Forecast & Y-o-Y Growth Analysis, 2021-2027
 11.4.3.9. Fibromyalgia
 11.4.3.9.1. Historical Market Value2016-2021 Market Value Forecast & Y-o-Y Growth Analysis, 2021-2027
 11.4.4. By Distribution Channel
 11.4.4.1. Introduction
 11.4.4.2. Strategic Insights
 11.4.4.2.1. BPS Analysis, By Distribution Channel
 11.4.4.2.2. Market Attractiveness, By Distribution Channel
 11.4.4.3. Hospitals Pharmacy
 11.4.4.3.1. Historical Market Value2016-2021 Market Value Forecast & Y-o-Y Growth Analysis, 2021-2027
 11.4.4.4. Retail Pharmacy
 11.4.4.4.1. Historical Market Value2016-2021 Market Value Forecast & Y-o-Y Growth Analysis, 2021-2027
 11.4.4.5. Online Pharmacy
 11.4.4.5.1. Historical Market Value2016-2021 Market Value Forecast & Y-o-Y Growth Analysis, 2021-2027
 11.4.5. By Country
 11.4.5.1. Introduction
 11.4.5.2. Strategic Insights
 11.4.5.2.1. BPS Analysis, By Country
 11.4.5.2.2. Market Attractiveness, By Country
 11.4.5.3. China Pain Therapeutics Market
 11.4.5.3.1. Historical Market Value2016-2021 Market Value Forecast & Y-o-Y Growth Analysis, 2021-2027
 11.4.5.4. India Pain Therapeutics Market
 11.4.5.4.1. Historical Market Value2016-2021 Market Value Forecast & Y-o-Y Growth Analysis, 2021-2027
 11.4.5.5. Japan Pain Therapeutics Market
 11.4.5.5.1. Historical Market Value2016-2021 Market Value Forecast & Y-o-Y Growth Analysis, 2021-2027
 11.4.5.6. South Korea Pain Therapeutics Market
 11.4.5.6.1. Historical Market Value2016-2021 Market Value Forecast & Y-o-Y Growth Analysis, 2021-2027
 11.4.5.7. Indonesia Pain Therapeutics Market
 11.4.5.7.1. Historical Market Value2016-2021 Market Value Forecast & Y-o-Y Growth Analysis, 2021-2027
 11.4.5.8. Taiwan Pain Therapeutics Market
 11.4.5.8.1. Historical Market Value2016-2021 Market Value Forecast & Y-o-Y Growth Analysis, 2021-2027
 11.4.5.9. Australia Pain Therapeutics Market
 11.4.5.9.1. Historical Market Value2016-2021 Market Value Forecast & Y-o-Y Growth Analysis, 2021-2027
 11.4.5.10. New Zealand Pain Therapeutics Market
 11.4.5.10.1. Historical Market Value2016-2021 Market Value Forecast & Y-o-Y Growth Analysis, 2021-2027
 11.4.5.11. Rest of Asia Pacific Pain Therapeutics Market
 11.4.5.11.1. Historical Market Value2016-2021 Market Value Forecast & Y-o-Y Growth Analysis, 2021-2027

11.5. Latin America Pain Therapeutics Market
 11.5.1. Historical Market Value2016-2021 Market Value Forecast & Y-o-Y Growth Analysis, 2021-2027
 11.5.2. By Drug Class
 11.5.2.1. Introduction
 11.5.2.2. Strategic Insights
 11.5.2.2.1. BPS Analysis, By Drug Class
 11.5.2.2.2. Market Attractiveness, By Drug Class
 11.5.2.3. NSAIDs
 11.5.2.3.1. Historical Market Value2016-2021 Market Value Forecast & Y-o-Y Growth Analysis, 2021-2027
 11.5.2.4. Anesthetics
 11.5.2.4.1. Historical Market Value2016-2021 Market Value Forecast & Y-o-Y Growth Analysis, 2021-2027
 11.5.2.5. Anticonvulsants
 11.5.2.5.1. Historical Market Value2016-2021 Market Value Forecast & Y-o-Y Growth Analysis, 2021-2027
 11.5.2.6. Antimigraine Agents
 11.5.2.6.1. Historical Market Value2016-2021 Market Value Forecast & Y-o-Y Growth Analysis, 2021-2027
 11.5.2.7. Antidepressants
 11.5.2.7.1. Historical Market Value2016-2021 Market Value Forecast & Y-o-Y Growth Analysis, 2021-2027
 11.5.2.8. Opioids
 11.5.2.8.1. Historical Market Value2016-2021 Market Value Forecast & Y-o-Y Growth Analysis, 2021-2027
 11.5.2.8.2. Tramadol
 11.5.2.8.2.1. Historical Market Value2016-2021 Market Value Forecast & Y-o-Y Growth Analysis, 2021-2027
 11.5.2.8.3. Hydrocodone
 11.5.2.8.3.1. Historical Market Value2016-2021 Market Value Forecast & Y-o-Y Growth Analysis, 2021-2027
 11.5.2.8.4. Oxycodone
 11.5.2.8.4.1. Historical Market Value2016-2021 Market Value Forecast & Y-o-Y Growth Analysis, 2021-2027
 11.5.2.8.5. Others
 11.5.2.8.5.1. Historical Market Value2016-2021 Market Value Forecast & Y-o-Y Growth Analysis, 2021-2027
 11.5.2.9. Nonnarcotic Analgesics
 11.5.2.9.1.1. Historical Market Value2016-2021 Market Value Forecast & Y-o-Y Growth Analysis, 2021-2027
 11.5.3. By Indication
 11.5.3.1. Introduction
 11.5.3.2. Strategic Insights
 11.5.3.2.1. BPS Analysis, By Indication
 11.5.3.2.2. Market Attractiveness, By Indication
 11.5.3.3. Arthritic Pain
 11.5.3.3.1. Historical Market Value2016-2021 Market Value Forecast & Y-o-Y Growth Analysis, 2021-2027
 11.5.3.4. Neuropathic Pain
 11.5.3.4.1. Historical Market Value2016-2021 Market Value Forecast & Y-o-Y Growth Analysis, 2021-2027
 11.5.3.5. Cancer Pain
 11.5.3.5.1. Historical Market Value2016-2021 Market Value Forecast & Y-o-Y Growth Analysis, 2021-2027
 11.5.3.6. Chronic Back Pain
 11.5.3.6.1. Historical Market Value2016-2021 Market Value Forecast & Y-o-Y Growth Analysis, 2021-2027
 11.5.3.7. Postoperative Pain
 11.5.3.7.1. Historical Market Value2016-2021 Market Value Forecast & Y-o-Y Growth Analysis, 2021-2027
 11.5.3.8. Migraine
 11.5.3.8.1. Historical Market Value2016-2021 Market Value Forecast & Y-o-Y Growth Analysis, 2021-2027
 11.5.3.9. Fibromyalgia
 11.5.3.9.1. Historical Market Value2016-2021 Market Value Forecast & Y-o-Y Growth Analysis, 2021-2027
 11.5.4. By Distribution Channel
 11.5.4.1. Introduction
 11.5.4.2. Strategic Insights
 11.5.4.2.1. BPS Analysis, By Distribution Channel
 11.5.4.2.2. Market Attractiveness, By Distribution Channel
 11.5.4.3. Hospitals Pharmacy
 11.5.4.3.1. Historical Market Value2016-2021 Market Value Forecast & Y-o-Y Growth Analysis, 2021-2027
 11.5.4.4. Retail Pharmacy
 11.5.4.4.1. Historical Market Value2016-2021 Market Value Forecast & Y-o-Y Growth Analysis, 2021-2027
 11.5.4.5. Online Pharmacy
 11.5.4.5.1. Historical Market Value2016-2021 Market Value Forecast & Y-o-Y Growth Analysis, 2021-2027
 11.5.5. By Country
 11.5.5.1. Introduction
 11.5.5.2. Strategic Insights
 11.5.5.2.1. BPS Analysis, By Country
 11.5.5.2.2. Market Attractiveness, By Country
 11.5.5.3. Brazil Pain Therapeutics Market
 11.5.5.3.1. Historical Market Value2016-2021 Market Value Forecast & Y-o-Y Growth Analysis, 2021-2027
 11.5.5.4. Mexico Pain Therapeutics Market
 11.5.5.4.1. Historical Market Value2016-2021 Market Value Forecast & Y-o-Y Growth Analysis, 2021-2027
 11.5.5.5. Rest of Latin America Pain Therapeutics Market
 11.5.5.5.1. Historical Market Value2016-2021 Market Value Forecast & Y-o-Y Growth Analysis, 2021-2027

11.6. Middle East & Africa Pain Therapeutics Market
 11.6.1. Historical Market Value2016-2021 Market Value Forecast & Y-o-Y Growth Analysis, 2021-2027
 11.6.2. By Drug Class
 11.6.2.1. Introduction
 11.6.2.2. Strategic Insights
 11.6.2.2.1. BPS Analysis, By Drug Class
 11.6.2.2.2. Market Attractiveness, By Drug Class
 11.6.2.3. NSAIDs
 11.6.2.3.1. Historical Market Value2016-2021 Market Value Forecast & Y-o-Y Growth Analysis, 2021-2027
 11.6.2.4. Anesthetics
 11.6.2.4.1. Historical Market Value2016-2021 Market Value Forecast & Y-o-Y Growth Analysis, 2021-2027
 11.6.2.5. Anticonvulsants
 11.6.2.5.1. Historical Market Value2016-2021 Market Value Forecast & Y-o-Y Growth Analysis, 2021-2027
 11.6.2.6. Antimigraine Agents
 11.6.2.6.1. Historical Market Value2016-2021 Market Value Forecast & Y-o-Y Growth Analysis, 2021-2027
 11.6.2.7. Antidepressants
 11.6.2.7.1. Historical Market Value2016-2021 Market Value Forecast & Y-o-Y Growth Analysis, 2021-2027
 11.6.2.8. Opioids
 11.6.2.8.1. Historical Market Value2016-2021 Market Value Forecast & Y-o-Y Growth Analysis, 2021-2027
 11.6.2.8.2. Tramadol
 11.6.2.8.2.1. Historical Market Value2016-2021 Market Value Forecast & Y-o-Y Growth Analysis, 2021-2027
 11.6.2.8.3. Hydrocodone
 11.6.2.8.3.1. Historical Market Value2016-2021 Market Value Forecast & Y-o-Y Growth Analysis, 2021-2027
 11.6.2.8.4. Oxycodone
 11.6.2.8.4.1. Historical Market Value2016-2021 Market Value Forecast & Y-o-Y Growth Analysis, 2021-2027
 11.6.2.8.5. Others
 11.6.2.8.5.1. Historical Market Value2016-2021 Market Value Forecast & Y-o-Y Growth Analysis, 2021-2027
 11.6.2.9. Nonnarcotic Analgesics
 11.6.2.9.1.1. Historical Market Value2016-2021 Market Value Forecast & Y-o-Y Growth Analysis, 2021-2027
 11.6.3. By Indication
 11.6.3.1. Introduction
 11.6.3.2. Strategic Insights
 11.6.3.2.1. BPS Analysis, By Indication
 11.6.3.2.2. Market Attractiveness, By Indication
 11.6.3.3. Arthritic Pain
 11.6.3.3.1. Historical Market Value2016-2021 Market Value Forecast & Y-o-Y Growth Analysis, 2021-2027
 11.6.3.4. Neuropathic Pain
 11.6.3.4.1. Historical Market Value2016-2021 Market Value Forecast & Y-o-Y Growth Analysis, 2021-2027
 11.6.3.5. Cancer Pain
 11.6.3.5.1. Historical Market Value2016-2021 Market Value Forecast & Y-o-Y Growth Analysis, 2021-2027
 11.6.3.6. Chronic Back Pain
 11.6.3.6.1. Historical Market Value2016-2021 Market Value Forecast & Y-o-Y Growth Analysis, 2021-2027
 11.6.3.7. Postoperative Pain
 11.6.3.7.1. Historical Market Value2016-2021 Market Value Forecast & Y-o-Y Growth Analysis, 2021-2027
 11.6.3.8. Migraine
 11.6.3.8.1. Historical Market Value2016-2021 Market Value Forecast & Y-o-Y Growth Analysis, 2021-2027
 11.6.3.9. Fibromyalgia
 11.6.3.9.1. Historical Market Value2016-2021 Market Value Forecast & Y-o-Y Growth Analysis, 2021-2027
 11.6.4. By Distribution Channel
 11.6.4.1. Introduction
 11.6.4.2. Strategic Insights
 11.6.4.2.1. BPS Analysis, By Distribution Channel
 11.6.4.2.2. Market Attractiveness, By Distribution Channel
 11.6.4.3. Hospitals Pharmacy
 11.6.4.3.1. Historical Market Value2016-2021 Market Value Forecast & Y-o-Y Growth Analysis, 2021-2027
 11.6.4.4. Retail Pharmacy
 11.6.4.4.1. Historical Market Value2016-2021 Market Value Forecast & Y-o-Y Growth Analysis, 2021-2027
 11.6.4.5. Online Pharmacy
 11.6.4.5.1. Historical Market Value2016-2021 Market Value Forecast & Y-o-Y Growth Analysis, 2021-2027
 11.6.5. By Geography
 11.6.5.1. Introduction
 11.6.5.2. Strategic Insights
 11.6.5.2.1. BPS Analysis, By Geography
 11.6.5.2.2. Market Attractiveness, By Geography
 11.6.5.3. GCC Pain Therapeutics Market
 11.6.5.3.1. Historical Market Value2016-2021 Market Value Forecast & Y-o-Y Growth Analysis, 2021-2027
 11.6.5.4. North Africa Pain Therapeutics Market
 11.6.5.4.1. Historical Market Value2016-2021 Market Value Forecast & Y-o-Y Growth Analysis, 2021-2027
 11.6.5.5. South Africa Pain Therapeutics Market
 11.6.5.5.1. Historical Market Value2016-2021 Market Value Forecast & Y-o-Y Growth Analysis, 2021-2027
 11.6.5.6. Rest of Middle East & Africa Pain Therapeutics Market
 11.6.5.6.1. Historical Market Value2016-2021 Market Value Forecast & Y-o-Y Growth Analysis, 2021-2027

12. Competitive Landscape
 12.1. Market Share of Key Players in Pain Therapeutics Market
 12.2. Pain Therapeutics Company Analysis
 12.2.1. NOVARTIS AG
 12.2.1.1. Company Overview
 12.2.1.2. Product Offered
 12.2.1.3. Business Strategy
 12.2.1.4. Financials
 12.2.1.5. SWOT Analysis
 12.2.1.6. Market Share Analysis
 12.2.1.7. Key Achievements & Developments
 12.2.2. ELI LILLY & COMPANY
 12.2.3. ABBOTT LABORATORIES, INC.
 12.2.4. ENDO HEALTH SOLUTIONS, INC.
 12.2.5. PURDUE PHARMA L.P.
 12.2.6. PFIZER, INC.
 12.2.7. F. HOFFMANN LA ROCHE LTD.
 12.2.8. MERCK & CO. INC.
 12.2.9. JOHNSON & JOHNSON
 12.2.10. GLAXOSMITHKLINE PLC.
 12.2.11. Other Major & Niche Players

13. Disclaimer